Lack of association between ABO histo-blood groups, secretor and non-secretor phenotypes, and anti-Toxoplasma gondii antibodies among pregnant women from the northwestern region of São Paulo State, Brazil

Archives of Medical Science

Volumn 4, Issue 3, 2008, Pages 254-258

  Brandao de Mattos, Cinara C ^a,b   Cintra, Juliana R ^b,c   Ferreira, Ana I C ^b   Spegiorin, Ligia C J F ^b   Galisteu, Katia J ^b   Machado, Ricardo L D ^a,b   de Mattos, Luiz Carlos ^a,b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^c Regional Blood Bank ^*  (Brazil)

Author keywords

ABO histo blood groups; FUT2 G428A; FUT2 gene; Secretor status; Toxoplasma gondii

Indexed keywords

BLOOD GROUP ABH ANTIGEN; FUCOSYLTRANSFERASE; GENE PRODUCT; GLYCOCONJUGATE; PROTEIN FUT2; PROTOZOON ANTIBODY; SECRETORY PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD SAMPLING; BRAZIL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; GENE SEQUENCE; HETEROZYGOSITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PROTEIN EXPRESSION; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 58549086792     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ortega-Barria E, Boothroyd JC. A Toxoplasma lectin-like activity specific for sulfated polysaccharides is involved in host cell infection. J Biol Chem 1999; 274: 12567-76.
2. Carruthers VB, Håkansson S, Giddings OK, Sibley LD. Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment. Infec Immun 2000; 68: 4005-11.
3. de Carvalho L, Souto-Padrón T, de Souza W. Localization of lectin-binding sites and sugar-binding proteins in tachyzoites of Toxoplasma gondii. J Parasitol 1991; 77: 156-61.
4. Schenkel-Brunner H. Human Blood Groups - Chemical and Biochemical Basis of Antigen Specificity. Viena: Springer Wien New York, 2000.
5. Oriol R. ABO, Hh, Lewis and secretion: serology, genetics and tissue distribution. In: Cartron, JP, Rouger, P. Blood Cell Biochemistry: Molecular Basis of Human Blood Group Antigens. New York: Plenum, 1995; 37-73.
6. Henry SM. Molecular diversity in the biosynthesis of GI tract glycoconjugates. A blood group related chart microorganism receptors. Transfus Clin Biol 2001; 8: 226-30.
7. Midtvedt T, Vaage L. Relationship between Toxoplasma gondii antibodies and blood group. Eur J Clin Microbiol Infec Dis 1989; 8: 575-6.
8. Lopes R, Fano R, Contreras R, Font L. Anticuerpos IgG anti-Toxoplasma gondii en Cubanos donantes de sangre. Rev Lat Amer Microbiol 1993; 35: 207-10.
9. Zhiburt EB, Ionova AI, Danil'chenko VV, Serebrianaia NB, Bel'gesov NV, Trofimenko EV. The spread of antibodies to cytomegalovirus and Toxoplasma among donors of blood components. Zh Mikrobiol Epidemiol Immunobiol 1997; 1: 59-61.
10. Kolbekova P, Kourbatova E, Novotna M, Kodym P, Flegr J. New and old risk factors for Toxoplasma gondii infection: prospective cross-sectional study among military personnel in the Czech Republic. Clin Microbiol Infect 2007; 13: 1012-7.
11. Gill HS. Occurrence of Toxoplasma gondii antibodies in Tanzanian blood donors. East Afr Med J 1985; 62: 585-8.
12. Lécolier B, Grynberg, Freund M. Absence of relationship between Toxoplasma gondii antibodies and blood group in pregnant women in France. Eur J Clin Microbiol Infect Dis 1990; 9: 152-3.
13. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215.
14. Svensson L, Petersson A, SM Henry. Secretor genotyping for A385T, G428A, C571T, C628T, 685delTGG, G849A, and other mutations from single PCR. Transfusion 2000; 40: 856-60.
15. Hohlfeld P, Daffos F, Thulliez P, et al. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatric 1989; 115: 765-9.
16. Raeber PA, Berger R, Biedermann K, et al. Prevention of congenital toxoplasmosis in Switzerland. Consensus report of the study group "Congenital toxoplasmosis" of the Federal Public Health Office. Schweiz Med Wochenschr Suppl 1995; 65: 113S-20S.
17. Morris A, Croxsson. Serological evidence of Toxoplasma gondii infection among pregnant women in Auckland. N Z Med J 2004; 117: U770.
18. Vela-Amieva M, Canêdo-Solares I, Gutiérrez-Castrellón P, et al. Short report: neonatal screening pilot study of Toxoplasma gondii congenital infection in Mexico. Am J Trop Med Hyg 2005; 72: 142-4.
19. Galǎo EA, de Godoy JM, Bagarelli LB, Perea LS, Oliani AH. Epidemiological aspects of the pregnant women with immunodeficiency virus in Brazil. Arch Med Sci 2007; 3: 142-4.
20. Mattos LC, Sanches FE, Cintra JR, et al. Genotipagem do locus ABO (9q34.1) em doadores de sangue da região noroeste do Estado de São Paulo. Rev Bras Hematol Hemoter 2001; 23: 15-22.
21. Cintra JR, Mattos LC. Freqüência relativa da substituiç-tiao G428A no gene FUT2. Rev Bras Hemat Hemoter 2006; 28: 335.
22. Galisteu, KJ, Mattos CCB, Lélis AL, et al. Prevalência e fatores de risco associados à toxoplasmose em grávidas e suas crianas no Noroeste Paulista, Brasil. Rev Pan Infec 2007; 9: 24-9.
23. Karlsson KA. Animal glycolipids as attachment sites for microbes. Chem Phys Lipids 1986; 42: 153-72.
24. Crane MS, Dvorak JA. Influence of monosaccharides on the infection of vertebrate cells by Trypanosoma cruzi and Toxoplasma gondii. Mol Bochem Parasitol 1982; 5: 333-41.
25. Ferreira IM, Vidal EJ, Costa-Silva TA, et al. Toxoplasma gondii: Genotyping of strains from Brazilian AIDS patients with cerebral toxoplasmosis by multilocus PCR-RFLP markers. Exp Parasitol 2007; 118: 221-7.